GSK-3145095 | m-entrepreneurship.com

Product Name :
GSK-3145095

Search keywords :
GSK3145095

drugId :
null

Target Vo:
Receptor-interacting serine/threonine-protein kinase 1

Target Vo Short Name :
RIP1

Moa_Name:
Receptor-interacting serine/threonine-protein kinase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Pancreatic Neoplasms

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
STAT1 Antibody (YA059)
E-Cadherin Antibody (YA778)
HOPX Antibody: HOPX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 8 kDa, targeting to HOPX. It can be used for WB, IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts